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Objective: Hematopoietic progenitor cells are able to induce neovascularization of
ischemic myocardium, inhibit apoptosis, and prevent heart failure. They express func-
tional CC chemokine-binding receptor 3 (CCR3) and CXC chemokine-binding recep-
tor 4 (CXCR4); however, the role of those receptors in migration of progenitor cells
into the ischemic myocardium is unknown.
Methods: Myocardial infarction was surgically induced in athymic nude rats, and hu-
man bone marrow–derived CD341 cells or saline was injected into the tail vein. Cell
chemotaxis was studied in vitro using chemotaxis chambers with or without concom-
itant stimulation with eotaxin or stromal cell–derived factor-1. Cell migration into is-
chemic myocardium was evaluated by immunohistochemistry. CCR3 and CXCR4
antibodies or local injections of stromal cell–derived factor-1 were used to investigate
the role of chemokine expression in the migration capacity of the injected cells. Mor-
phologic analysis included evaluation of apoptosis and capillary density in the ische-
mic myocardium.
Results: Ischemic rat myocardium demonstrated induced messenger RNA expression
for the CCR3-binding chemokines eotaxin, RANTES (regulated on activation, nor-
mal T expressed and secreted), and monocyte chemotactic protein-3, but not the
CXCR4-binding chemokine stromal cell–derived factor-1. Migration of human an-
gioblasts to ischemic rat myocardium was inhibited by a blocking anti-CCR3 mono-
clonal antibody, but not by a blocking anti-CXCR4 monoclonal antibody, which
instead inhibited migration to bone marrow. Finally, intramyocardial injection of stro-
mal cell–derived factor-1 redirected migration of human angioblasts to ischemic rat
hearts, resulting in augmented neovascularization, enhanced cardiomyocyte survival,
and functional cardiac recovery.
Conclusions: CCR3-dependent chemokine interactions regulate endogenous migra-
tion of CD341 progenitors from bone marrow to ischemic but not to normal myocar-
dium. Manipulating CXCR4-dependent interactions could enhance the efficacy of cell
therapy after myocardial infarction.
I
n normal adult animals, CD341 hematopoietic progenitors continuously migrate
between the bone marrow and the intravascular compartment.1 Bone marrow
homing and retention of CD341 hematopoietic progenitors in adult mammals
are processes controlled by a number of adhesive interactions,2,3 including those be-
tween the CXC chemokine stromal cell–derived factor-1 (SDF-1), which is constitu-
tively produced by bone marrow stromal cells, and its receptor, CXCR4.4,5 Disruption
of bone marrow SDF-1/CXCR4 interactions,6 as occurs after activation of neutrophil
proteases by systemic administration of granulocyte-colony stimulating factor (G-
CSF), results in transient egress of hematopoietic progenitors from the bone marrow
into the peripheral circulation, a phenomenon termed mobilization.7 These observa-
tions form the basis of clinical protocols enabling large scale harvesting of bone
From the Department of Cardiac Surgery
Innsbruck Medical University, Innsburck,
Austria,a and the Departments of Medicine,
Surgery, and Pathology, Columbia Univer-
sity, New York, NY.b
Michael Schuster reports consulting fees
and equity from Angioblast Systems and
Mesoblast Limited; he is an employee of
Angioblast Systems. Silviu Itescu reports
consulting fees and equity from Angioblast
Systems and Mesoblast Limited; he is an
officer of Angioblast Systems. Angioblast
Systems has a license for production of
eotaxin.
* These authors contributed equally.
Received for publication Oct 5, 2007;
revisions received Dec 6, 2007; accepted
for publication Dec 24, 2007.
Address for reprints: Nikolaos Bonaros,
MD, Department of Cardiac Surgery, Inns-
bruck Medical University, Anichstrasse 35,
A-6020, Innsbruck, Austria (E-mail:
nikolaos.bonaros@i-med.ac.at).
J Thorac Cardiovasc Surg 2008;136:1044-
53
0022-5223/$34.00
Copyright  2008 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.12.0671044 The Journal of Thoracic and Cardiovascular Surgery c October 2008
Bonaros et al Cardiopulmonary Support and Physiology
CS
PAbbreviations and Acronyms
CCR3 5 CC chemokine-binding receptor 3
CXCR4 5 CXC chemokine-binding receptor 4
FDG 5 18F-fluoro-2-deoxy-D-glucose
G-CSF 5 granulocyte-colony stimulating factor
LAD 5 left anterior descending coronary artery
mAb 5 monoclonal antibody
MCP-3 5 monocyte chemotactic protein-3
MHC 5 major histocompatibility complex
RANTES 5 regulated on activation, normal
T expressed and secreted
RPL32 5 ribosomal protein L32
SCF 5 stem cell factor
SDF-1 5 stromal cell–derived factor-1
VCAM-1 5 vascular cell adhesion molecule
VEGF 5 vascular endothelial growth factor
VEGFR-2 5 vascular endothelial growth factor
receptor-2
marrow CD341 progenitors for autologous stem cell trans-
plantation in certain hematologic disorders.
Bone marrow–derived CD341 progenitors are capable of
giving rise to cells of nonhematopoietic lineage, including
hepatocytes,8 epithelial cells,9 and endothelial cells.10 We10
have reported that G-CSF–mobilized human adult bone
marrow elements contain CD341 progenitors with pheno-
typic and functional characteristics of embryonic angioblasts
that, when transplanted into animal models of acute myocar-
dial infarction, home to ischemic myocardium, induce
neovascularization, and result in improved cardiac outcome.
Similar results have been obtained with autologous bone
marrow cells in humans with acute myocardial ischemia.11,12
Collectively, these studies suggest that a general mechanism
by which endogenous repair of damaged tissues occurs is
redirected migration of CD341 progenitors from the bone
marrow to sites of acute injury, including the heart.
In adult mice, bone marrow progenitors capable of
hematopoietic reconstitution have been reported to constitu-
tively express several chemokine receptors, including CXC
chemokine-binding receptor 4 (CXCR4) and CC chemo-
kine-binding receptor 3 (CCR3), but to demonstrate re-
stricted chemotactic responses only to SDF-1.13 In contrast,
human CD341 bone marrow and cord blood cells, which
contain both hematopoietic and nonhematopoietic progeni-
tors, demonstrate robust chemotactic responses to diverse
chemokines in addition to SDF-1, including migration to
nonhematopoietic sites in response to the CCR3-binding
CC chemokine eotaxin.14,15 In this study, we investigated
the nature of the endogenous chemotactic signals provided
by ischemic myocardium that result in migration of human
bone marrow–derived angioblasts to the heart to identify
strategies to enhance cell migration into the ischemic myo-
cardium.The Journal of ThoraMethods
Purification and Characterization of Cytokine-
mobilized Human CD341 Cells
Single-donor leukopheresis products were obtained from humans
treated with recombinant G-CSF 10 mg/kg (Amgen, Thousand
Oaks, Calif) subcutaneously daily for 4 days after approval by the
ethical committee of Columbia University. Mononuclear cells
were separated by Ficoll–Hypaque, and highly purified CD341
cells (.98% positive) were obtained using magnetic beads coated
with anti-CD34 monoclonal antibody (mAb) (Miltenyi Biotech,
Auburn, Calif). Purified CD34 cells were stained with fluorescein-
conjugated mAbs against CD34 and CD117 (Becton Dickinson,
Franklin Lakes, NJ), AC133 (Miltenyi Biotech), CD54 (Immuno-
tech, Fullerton, Calif), CD62E (BioSource, Inc, Worcester, Mass),
vascular endothelial growth factor receptor-2 (VEGFR-2), Tie-2,
von Willebrand factor, endothelial nitric oxide synthase, CXCR1,
CXCR2, and CXCR4 (all Santa Cruz Biotech, Santa Cruz, Calif),
and analyzed by four-parameter fluorescence using FACScan
(Becton Dickinson). Cells positively selected for CD34 expression
were also stained with phycoerythrin-conjugated anti-CD117 mAb
(Becton Dickinson) and sorted for bright and dim fluorescence using
a Facstar Plus (Becton Dickinson) and a phycoerythrin filter.
Indium 111 Labeling of Bone Marrow–derived
CD341 Progenitors
G-CSF–mobilized cells were immunoselected for CD341 expres-
sion and resuspended in medium containing 20 mCi of 111In
8-oxyquinoline (oxine) per 108 cells as described before.16 After
washing, 23 106 111In 8-oxyquinoline (oxine) labeled CD341 cells
were infused intravenously into the nude rats 24 hours after myocar-
dial infarction or into noninfarcted animals. Twenty-four hours later,
animals were humanely killed and organs were harvested. Indium
111 counts in each tissue were measured with a gamma spectrometer
and calibrated as desintegration per minute per gram tissue using the
counter efficiency. Postlabeling viability exceeded 80% and prelim-
inary experiments demonstrated adequate cell tracking.
Chemotaxis of Human Bone Marrow–derived
Hematopoietic Progenitors
Highly purified CD341CD1171 cells (.98% purity) were plated
in 48-well chemotaxis chambers fitted with membranes (8-mm
pores) (Neuro-Probe, Inc, Gaithersburg, Md). After incubation for
2 hours at 37C, chambers were inverted and cells were cultured
for 3 hours in medium containing eotaxin or SDF-1 at concentra-
tions of 0.2, 1.0, and 5.0 mg/mL. Stem cell factor (SCF) was used
as negative control in chemotaxis assays at 0.1 mg/mL, a biologically
active concentration that induced 2-fold proliferation of
CD341CD117bright cells after culture for 96 hours. The membranes
were fixed with methanol and stained with Leukostat (Fischer
Scientific, Pittsburgh, Pa). Chemotaxis was calculated by counting
migrating cells in 10 high-power fields.
Animals, Surgical Procedures, and Injection of
Human Cells
Rowett (rnu/rnu) athymic nude rats (Harlan Sprague Dawley, Inc,
Indianapolis, Ind) were used in studies approved by the Columbia
University Institute for Animal Care and Use Committee. After an-
esthesia, a left thoracotomy was performed, the pericardium wascic and Cardiovascular Surgery c Volume 136, Number 4 1045
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CSPopened, and the left anterior descending (LAD) coronary artery was
ligated. Sham-operated rats had a similar surgical procedure without
having a suture placed around the coronary artery. For studies on
cellular migration, 2.0 3 106 DiI-labeled CD341 cells obtained
from a single donor after G-CSF mobilization were injected into
the tail vein 48 hours after LAD ligation in the presence or absence
of mAbs with known inhibitory activity against CCR3 (100 mg),
CXCR4 (200 mg), CD34 (100 mg), or isotype control antibodies. In-
hibiting antibodies were injected in the ischemic area using 3 to 5
injections. Control animals received saline after LAD ligation, and
2.0 3 l06 CD341 human cells were also injected into the tail vein
of sham-operated or LAD-ligated rats receiving three intramyocar-
dial injections of 1.0 mg/mL eotaxin, SDF-1, VEGF, SCF, or saline.
Quantitation of Cellular Migration Into Tissues
After intravenous injection of human cells, quantitative analysis of
the proportion of human cells in rat bone marrow and heart was per-
formed by assessment of both DiI fluorescence and expression of
major histocompatibility complex (MHC) class I proteins in rats hu-
manely killed 2 days after injection. Single cell suspension of rat
bone marrow was stained with fluorescein-conjugated mAbs against
human CD34 and MHC class I beta2 microglobulin (Accurate
Chemical & Scientific Corporation, Meriden, Conn) and analyzed
by multiparameter fluorescence using FACScan (Becton Dickin-
son,), as described previously.17 The proportion of human cells in
rat heart tissue was expressed as the number of DiI-positive cells
per high-power field (minimum 5 fields examined per sample) and
as the proportion of cells staining positive for human MHC class I
beta2 microglobulin (Accurate Chemical & Scientific Corporation).
Cardiac tissue was stained by immunoperoxidase technique using an
Avidin/Biotin Blocking Kit, a rat-absorbed biotinylated antimouse
immunoglobulin G, and a peroxidase–conjugate (all Vector Labora-
tories, Burlingame, Calif). The human origin of the detected cells
was confirmed by staining against the human–mitochondrial epitope
S-100 (S1-61; Santa Cruz Biotech).
Measurement of Rat Myocardial Chemokine
Messenger RNA (mRNA) Expression
Total RNA was isolated from heart tissues of 3 normal and 12 LAD-
ligated rats using the RNAqueous kit from Ambion (Austin, Tex)
and was converted to complementary DNA with SuperScript First
Strand Synthesis System for RT-PCR from Invitrogen (Carlsbad,
Calif). Reverse-transcriptase polymerase chain reaction was used to
quantify myocardial expression of rat eotaxin, regulated on activation,
normal T expressed and secreted (RANTES), monocyte chemotactic
protein-3 (MCP-3), and SDF-1 mRNA at baseline, and at 6, 12, 24,
and 48 hours after LAD ligation after normalizing for rat RNA content
using rat ribosomal protein L32 (RPL32) mRNA expression. Primer
sequences for rat SDF-1 alpha were 50-CTGTTGTGCTTACTTGTTT
AAGGCTTTGTC-30 for forward primer and 50-GACGCCAAGGTC
GTCGGT-30 for reverse primer. For rat ribosomal protein L32, primers
were 50-CCCTTCGGCCTCTGGTGAAGC-30 for forward primer and
50-GAACACAAAAACAGGCACACAAGCCATC-30 for reverse
primer. Primer sequences for rat MCP-3 50-TTTCACCGTGCACG
TGTGGG-30 for forward primer and 50-GTCTTCAGGGCTTTGG
AGTTG-30 for reverse primer. Primer sequences for rat RANTES
were 50-ACCTGCCTCCCCATATGGCT-30 for forward primer and
50-GTATTCTTGAACCCACTTCTTC-30 for reverse primer. Primer1046 The Journal of Thoracic and Cardiovascular Surgery c Ocsequences for rat eotaxin were 50-TTCTATTCCTGCTGCTCA-30
for forward primer and 50-CCTGGACCCACTTTTTCT-30 for reverse
primer. PCR was performed with the GeneAmp PCR System 9700
(ABI, Foster City, Calif). Amplification was for 1 minute at 94 cycles,
27 cycles (RPL32) or 32 cycles (SDF-1, RANTES, MCP-3) with 30
seconds at 94 cycles and 1 minute at 68 cycles, followed by 5 minutes
at 68 cycles. PCR products were analyzed on agarose gel stained with
ethidium bromide. Reverse-transcriptase polymerase chain reaction
products were scanned and quantified by UN-SCAN-IT software
from Silk Scientific Inc (Orem, Utah). Values of eotaxin, RANTES,
MCP-3, and SDF-1 expression were calculated relative to the values
of RPL32 expression. Data were expressed as the means obtained
from three independent rats for each time point.
Quantitation of Capillary Density
To quantitate capillary density and species origin of the capillaries,
we stained additional sections with mAbs directed against rat or
human CD31 (AbD Serotec, Oxford, United Kingdom, and Re-
search Diagnostics, Inc, Flanders, NJ, respectively), factor VIII
(Dako, Carpinteria, Calif), and rat or human MHC class I (Accurate
& Scientific Corporation), as described before.17
Measurement of Myocyte Apoptosis by DNA End
Labeling of Paraffin Tissue Sections
For in situ detection of apoptosis at the single cell level, we used the
terminal deoxynucleotidyl transferase–mediated dUTP nick end
labeling method of DNA end labeling mediated by dexynucleotidyl
transferase (Boehringer Mannheim, Mannheim, Germany), as previ-
ously described.17
Quantification of Infarct Size
A Masson trichrome stain was performed to evaluate collagen
content. This enabled measurement of the size of the myocardial
scar using a digital image analyzer. Infarct area was measured
with a planimeter digital image analyzer and expressed as a percent-
age of the total ventricular circumference.
Analyses of Myocardial Function
Echocardiographic studies were performed with a high-frequency
linear array transducer (SONOS 5500, Hewlett Packard, Andover,
Mass). Two-dimensional images were obtained at midpapillary
and apical levels. End-diastolic (EDV) and end-systolic (ESV) left
ventricular volumes were obtained by biplane area–length method,
and percent left ventricular ejection fraction was calculated as
([EDV 2 ESV]/EDV) 3 100.
18F-Fluoro-2-Deoxy-D-Glucose (FDG) Positron
Emission Tomography
Imaging studies were performed in rats using a Concorde R4 mPET
small animal positron emission tomography imaging system after
administration of FDG as described in a previous publication.17
Results
G-CSF Mobilized Human Bone Marrow Angioblasts
Selectively Migrate to Ischemic Myocardium in Vivo
In the absence of ischemia, the majority of intravenously in-
jected human cells were trapped in the rat liver, spleen, andtober 2008
Bonaros et al Cardiopulmonary Support and PhysiologyFigure 1. G-CSF mobilized human bone marrow
CD341 prognitors selectively migrate to ischemic
myocardium in vivo. A, Detection of indium 111–
labeled human bone marrow CD341 progenitors
at different organs. B, Fluorescence microscopy
shows positive cell engraftment in the infarct
area as detected by DiI fluorescence (the side
panel represents a negative control). C, Verifica-
tion of cell engraftment by detection of MHC class
I beta-2 microglobulin in the ischemic area by
means of immunohistochemistry (the side panel
represents a negative control). D, The human ori-
gin of the cells was confirmed by staining against
the human mitochondrial epitope S-100.CS
Plungs, with only 3.2% migrating to the nonischemic heart. In
contrast, after LAD ligation, 23% of the intravenously in-
jected human cells were present in the heart 24 hours after in-
jection (P, .01). Moreover, the heart was the only rat organ
demonstrating a significant increase in migration of human
cells after acute myocardial ischemia, with 7.1-fold increase
in the indium 111 desintegration per minute count relative to
nonischemic myocardium (P , .01) (Figure 1). A detailed
examination of cell migration to the heart revealed that
69.1% and 25.4% of the cells were detected at the infarction
area and the periinfarct zone, respectively. Detection of in-
jected cells at nonischemic myocardium accounted for less
than 5%.
G-CSF–Mobilized Human Bone Marrow Angioblasts
Express CCR3 and CXCR4 Chemokine Receptors
To identify potential chemokine receptor–ligand interactions in-
volved in chemotaxis of G-CSF–mobilized angioblasts to the
ischemic myocardium, we examined the CD341CD117bright
human angioblasts for surface expression of chemokine recep-
tors, specifically the CCR3, which binds the CC chemokines
eotaxin, RANTES, and MCP-3, and the CXCR4, which binds
the CXC chemokine SDF-1. Shown in Figure 2, A, is CD117
expression on G-CSF–mobilized human CD341 cells,
identifying the dual staining CD117bright population previously
shown to contain the angioblast fraction. The
CD341CD117bright population expressed both CCR3 and
CXCR4 receptors.The Journal of ThoraLigation of CCR3 and CXCR4 Chemokine Receptors
Induces in Vitro Migration of G-CSF–Mobilized
Human Bone Marrow Angioblasts
To examine the functional activity of CCR3 and CXCR4 re-
ceptors on the angioblasts, we measured in vitro chemotaxis
of CD341CD117bright human bone marrow cells after trig-
gering these receptors with their specific ligands, respec-
tively, eotaxin and SDF-1. As shown in Figure 2, B, human
angioblasts demonstrated significant in vitro chemotactic re-
sponses to both eotaxin and SDF-1. In contrast, SCF, used as
a negative control, was not chemotactic for this cellular pop-
ulation at a biologically active concentration, which induced
2-fold proliferation of CD341CD117bright cells after culture
for 96 hours.
Acute Myocardial Ischemia Is Associated With
Increased mRNA Expression of CCR3-binding
Chemokines, but not CXCR4-binding Chemokines
Next, we examined rat myocardial tissue at various time-
points after LAD ligation to determine whether there was
induced mRNA expression of the CCR3-binding CC chemo-
kines eotaxin, RANTES, and MCP-3, and of the CXCR4-
binding CXC chemokine SDF-1. As shown in Figure 3, A,
after LAD ligation, rat myocardium demonstrated a time-de-
pendent increase in eotaxin mRNA expression, with 3-fold
induction above baseline being seen at 12 hours, and elevated
levels returning to normal by 48 hours (P , .001). Induced
expression of RANTES and MCP-3 mRNA was also noted,cic and Cardiovascular Surgery c Volume 136, Number 4 1047
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CSPwith maximal levels by 12 hours (Figure 3, B and C; both
P , .01). In contrast, by 12 hours after acute myocardial
ischemia, SDF-1 mRNA expression in the heart decreased
by a mean of 43% (P , .01; Figure 3, D).
CCR3-binding Chemokines Regulate Migration of
Human CD341 Progenitors to Ischemic
Myocardium, Whereas CXCR4 Binding Regulates
Migration to Bone Marrow
We next sought to directly demonstrate that interactions
between myocardial CCR3-binding chemokines and CCR3
receptors on human CD341 progenitors contributed to myo-
cardial homing of bone marrow angioblasts in LAD-ligated
rats. As shown in Figure 4, A, co-administration of a blocking
mAb against CCR3 reduced myocardial trafficking of intra-
venously injected human bone marrow–derived CD341 pro-
genitors at 48 hours by a mean of 60% relative to isotype1048 The Journal of Thoracic and Cardiovascular Surgery c Ocontrol antibodies (P , .01). In contrast, mAbs directed to
other surface receptors present on these cells, such as
CD34 or VEGF-R, as well as against CXCR4, did not inhibit
migration to the ischemic myocardium. Moreover, anti-
CXCR4 mAb inhibited migration of human CD341 progen-
itors to rat bone marrow by a mean of 80% (P, .01), whereas
isotype control antibodies were without effect (Figure 4, B).
Manipulating CCR3- and CXCR4-dependent
Interactions Increases Migration of Human CD341
Progenitors to Myocardial Tissue
To definitively prove that CCR3-dependent interactions
could redirect human CD341 bone marrow progenitors to
the heart in vivo, we injected human recombinant eotaxin at
1.0 mg/mL into noninfarcted rat hearts concomitantly with
intravenous injection of human angioblasts. As shown in
Figure 4, C, this resulted in 2.3-fold increases in myocardialFigure 2. G-CSF mobilized human bone
marrow–derived angioblasts express
chemokine receptors CCR3 and CXCR4,
and demonstrate in vitro chemotactic
responses to their ligands, eotaxin and
SDF-1. A, Four-parameter flow cytomet-
ric phenotypic characterization of G-
CSF–mobilized bone marrow–derived
cells obtained by leukopharesis from
a representative human donor adult.
Only live cells were analyzed, as de-
fined by 7-AAD staining. For each
marker used, open areas represent
background log fluorescence relative
to isotype control antibody. The angio-
blast fraction has previously been char-
acterized to reside in the minor CD341
population expressing CD117 brightly.
The CD341CD117bright angioblast sub-
set expresses CXCR4 and CCR3. The in-
jected CD341 cells had a purity of
greater than 98%; 90% to 95% co-ex-
pressed the hematopoietic lineage
marker CD45, 60% to 80% co-expressed
the SCF receptor CD117, and less than
1% co-expressed the monocyte/macro-
phage lineage marker CD14. B, Results
of in vitro chemotaxis of human angio-
blasts in response to various conditions
using a 48-well chemotaxis chamber
(Neuro Probe, Inc, Gaithersburg, Md).
Chemotaxis is defined as the number
of migrating cells per high-power field
after examination of 10 high-power
fields per condition tested. Chemotaxis
is increased in response to eotaxin
and SDF-1 (both P< .01), but not SCF (re-
sults are expressed as mean6 SEM of 3
separate experiments).ctober 2008
Bonaros et al Cardiopulmonary Support and PhysiologyFigure 3. Increasedmyocardial mRNA expression of CCR3-binding chemokines, but not CXCR4-binding chemokines,
after acute ischemia. A to D, Chemokine mRNA expression in rat myocardial tissue examined at various time-points
after LAD ligation relative to constitutive expression of RPL32 to determine whether there was induced mRNA ex-
pression of the CCR3-binding CC chemokines eotaxin, RANTES, and MCP-3, and of the CXCR4-binding CXC chemo-
kine SDF-1. Induced expression of eotaxin, RANTES, andMCP-3 mRNAwas noted, with maximal mRNA levels by 6 to
12 hours (all P< .01). In contrast, by 12 hours after acute myocardial ischemia, SDF-1 mRNA expression decreased
by a mean of 43% in cardiac tissue (P < .01) (results are expressed as mean 6 SEM of 3 separate experiments).CS
Pinfiltration by human CD341 progenitors at 48 hours (P ,
.01), whereas SCF and VEGF, used as negative controls, had
little effect. Intramyocardial injection of SDF-1 of 1.0 mg/mL
was also effective, inducing a 2.5-fold increase in angioblast
chemotaxis to normal rat hearts (P , .01). However, no
increase in myocardial neovascularization was observed at
2 weeks after eotaxin or SDF-1 injection (data not shown),
suggesting that additional factors produced under ischemic
conditions are necessary for angioblast differentiation into
mature hematopoietic cells and subsequent new blood vessel
formation.
Intramyocardial SDF-1 Augments
Neovascularization, Protects Against Cardiomyocyte
Apoptosis, and Induces Functional Recovery
We finally examined whether increasing myocardial expres-
sion of SDF-1 could result in increased angioblast homing
to the ischemic heart and augment angioblast-dependent
neovascularization and cardiomyocyte survival after acute
ischemia. As shown in Figure 5, A and B, co-administration
of intramyocardial SDF-1 induced 2-fold greater myocardial
neovascularization accompanying intravenous angioblast
injection (P, .01) and induced 76% further reduction in car-
diomyocyte apoptosis (P , .01). Moreover, co-administra-
tion of intramyocardial SDF-1 together with intravenousThe Journal of Thorangioblasts resulted in an almost 3-fold greater improvement
in left ventricular ejection fraction as compared with intrave-
nous injection of angioblasts alone (Figure 5, C; P , .01).
Quantification of the infarct size showed a 32% reduction
in animals treated with both local SDF-1 application and in-
jection of CD341 cells, as compared with a 19% reduction
detected after single CD341 cell injections (P5 .031). In ad-
dition, myocardial perfusion studies using FDG uptake
showed a significantly improved tissue perfusion after com-
bined treatment as compared with CD341 cell administra-
tion alone (P 5 .004) (Figure 6).
Discussion
Chemokine receptor–ligand interactions play a major role in
leukocyte traffic and recruitment to sites of tissue damage
or inflammation.18,19 In this study, we have shown that
human CD341 bone marrow progenitors, which include
CD117bright angioblasts or hematopoietic progenitor cells,
use two alternative chemokine receptor–ligand pairs to mi-
grate to bone marrow or ischemic myocardium. The site of
directed migration was primarily dependent on the specificity
of locally induced chemokines, rather than alterations in che-
mokine receptor expression. Migration to the bone marrow
was CXCR4-dependent in response to constitutive expres-
sion of the CXCR4-binding chemokine SDF-1 at this site.acic and Cardiovascular Surgery c Volume 136, Number 4 1049
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CSPFigure 4. CCR3-binding chemokines regulate migration of human CD341 progenitors to ischemic myocardium,
whereas CXCR4-binding regulates migration to bone marrow. A, Migration of human angioblasts to ischemic rat
myocardium at 2 days after intravenous injection is inhibited by antihuman CCR3 mAb (P < .01), but not by mAbs
against CXCR4, Flk-1, or isotype control (results are expressed as mean 6 SEM of 3 separate experiments). B,
the proportion of human CD341CD117bright angioblasts in rat bone marrow at 2 days after intravenous injection is
significantly decreased by co-administration of anti-CXCR4 mAb (results are expressed as mean 6 SEM of bone
marrow studies in 3 animals at each time point). c, Intracardiac injection of eotaxin or SDF-1 at 1 mg/mL significantly
increases in vivo chemotaxis of DiI-labeled human angioblasts (98% CD341 purity) into nonischemic rat myocar-
dium in comparisonwith injection of saline or (SCF, both P< .01 (results are expressed as mean6 SEM of 3 separate
experiments). Below are shown representative examples of DiI fluorescence microscopy in nonischemic rat hearts
after intravenous angioblast administration accompanied by intracardiac injection with eotaxin or SDF-1.In contrast, migration to ischemic rat myocardium was
CCR3- but not CXCR4-dependent, in response to induced
mRNA expression of the CCR3-binding chemokines eo-
taxin, RANTES, and MCP-3, but not SDF-1. However, intra-
myocardial injection of SDF-1 redirected migration of human
angioblasts to ischemic rat hearts, resulting in augmented
neovascularizarion, enhanced cardiomyocyte survival, and
functional cardiac recovery. These results demonstrate the
feasibility of manipulating chemokine receptor–ligand inter-
actions for therapy of cardiovascular disease and suggest that
augmenting CXCR4-dependent interactions at extrahemato-
poietic sites could provide a general paradigm for enhancing
hypoxic or ischemic tissue repair by bone marrow–derived
hematopoietic progenitors. Our study elaborated on the role
of CCR3- and CXCR4-mediated chemoattraction in the early
phase after acute myocardial infarction, and data on the mid-
term and long-term cell survival in ischemic myocardium
were not included.1050 The Journal of Thoracic and Cardiovascular Surgery c OcHoming and retention of hematopoietic progenitors in
mammalian bone marrow are processes controlled by a num-
ber of adhesive interactions between stromal cells and hema-
topoietic progenitors.2,3 Binding of SDF-1 to its ligand,
CXCR4, results in augmented interactions between integrin
receptor–ligand pairs, including very late antigen-4 and vascu-
lar cell adhesion molecule (VCAM-1)/CD106,19 which serve
to tether and retain very late antigen-4 expressing progenitors
to VCAM-1/CD106 positive stromal cells in the bone marrow.
Systemic treatment with G-CSF induces activation of neutro-
phil precursors in the bone marrow and their subsequent secre-
tion of neutrophil proteases, which directly cleave the
N-terminal regions of SDF-1 and CXCR4, as well as
VCAM-1.6,7 Inasmuch as this results in egress of hematopoi-
etic progenitors from the bone marrow into the peripheral
circulation, G-CSF administration may facilitate myocardial
migration of CD341CD117bright angioblasts in response to
CCR3-binding chemokines induced in the ischemic heart.tober 2008
Bonaros et al Cardiopulmonary Support and PhysiologyFigure 5. Intramyocardial injection of SDF-1 increases angioblast chemotaxis to ischemic myocardium, augmenting
neovascularization, cardiomyocyte survival, and functional cardiac recovery. Intracardiac injection of SDF-1 into
infarcted rat hearts in combination with intravenously-injected CD341 human bone marrow cells resulted in a fur-
ther 2-fold increase in capillary numbers (A), in a further reduction in cardiomyocyte apoptosis of 76% (B), and in
a further reduction in infarct size (C) as compared with intravenously-injected angioblasts alone (all P < .001).
The results of vascular density are expressed as mean 6 SEM of 3 separate experiments. Large diameter vessels
include vessels built by more than 6 nuclei and with a diameter greater than 20 mm. Representative staining against
factor VIII and Masson trichrome stain shows increased vasculary density and reduced infarct scar, respectively, in
treated animals (i) as compared with controls (ii). (D). Intracardiac co-administration of SDF-1 results in 4-fold
greater improvement in left ventricular ejection fraction, determined by echocardiography, compared with intrave-
nous injection of CD341 human bone marrow cells alone (P< .01). Results are expressed as mean6 SEM of 3 sep-
arate experiments.CS
PEotaxin is principally produced by smooth muscle cells and
fibroblasts in subendothelial tissue locations,20 and its expres-
sion is typically associated with the recruitment of eosinophils
and basophils to inflamed tissues and their accumulation dur-
ing certain inflammatory processes, such as allergy and
asthma.21 The eotaxin receptor, CCR3, is expressed on eosin-
ophils, basophils, mast cells, and the Th2 subset of T cells, and
also binds the chemokines RANTES and MCP-3 with high af-
finity, but not other CC or CXC chemokines.22-24 Increased
levels of eotaxin in autoimmune myocardial inflammation
and during rejection episodes of transplanted heart confirm
its crucial role as chemoattractant in myocardial tissue.25,26
Constitutive expression of CCR3 has also been reported
by human and mouse bone marrow progenitors as well asThe Journal of Thordendritic cells.14,15 However, whereas CD341 eosinophil
and dendritic bone marrow–derived progenitors demonstrate
CCR3-dependent chemotactic responses,23-25 mouse hemato-
poietic stem cells that home to the bone marrow and recapitu-
late hematopoiesis do not.13 These observations suggest that
CCR3-dependent chemokine interactions direct migration of
bone marrow–derived leukocyte progenitors away from the
marrow to distal sites of tissue damage and inflammation. In
support of these conclusions, CCR3-deficient mice demon-
strate altered migration of eosinophils and mast cells, respec-
tively, to the intestine and lungs.24 Our results extend these
observations to migration of human CD341CD117bright
bone marrow progenitors to the site of myocardial ischemia
where expression of eotaxin, RANTES, and MCP-3 mRNAacic and Cardiovascular Surgery c Volume 136, Number 4 1051
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CSPFigure 6. Emmission tomography shows that in-
tracardiac administration of SDF-1 results in an
almost 2-fold increase of FDG uptake in animals
treated with local administration of SDF-1 and
injection of CD341 cells, as compared with ani-
mals subjected to injection of CD341 cells alone
(P < .01).was induced. Moreover, since hypoxia is a stimulus for induc-
tion of eotaxin mRNA,27 we hypothesize that CCR3-directed
chemotaxis of human CD341CD117bright angioblasts or he-
matopoietic progenitors contributes to neovascularization of
hypoxic or damaged tissues throughout the body.
SDF-1, a biologically active chemotactic factor for human
endothelial progenitors,28 augmented angioblast-dependent
myocardial chemotaxis, neovascularization, cardiomyocyte
survival, and functional cardiac recovery when directly in-
jected into the ischemic myocardium. Together with results
from adult humans in whom SDF-1 expression at extrahema-
topoietic sites is accompanied by aberrant neovasculariza-
tion,28 our data demonstrate that SDF-1 expression at sites
outside the bone marrow can play a major role in induction1052 The Journal of Thoracic and Cardiovascular Surgery c October 2008
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CS
Pof tissue neovascularization by bone marrow–derived hema-
topoietic progenitors. These conclusions are supported by re-
cent studies using SDF-1 in an animal model of reduced hind
limb perfusion29 and in genetically engineered skeletal myo-
blasts implanted into ischemic myocardium.30
Together, our results suggest that redirected migration of
CD341 progenitors from the bone marrow to sites of acute
injury may represent a general mechanism by which endog-
enous repair of damaged tissues occurs, and that the specific-
ity of the migratory pattern is governed by the induced
chemokine profile in a given injured tissue. Moreover, our re-
sults suggest that it may be possible to selectively activate
CXCR4- or CCR3-dependent chemotactic pathways to direct
migration of CD341 progenitors to sites of tissue ischemia or
damage and induce therapeutic neovascularization for tissue
repair. The effect of this combined approach using autolo-
gous cells injections in immunocompetent hosts is required
to address the question of clinical applicability.
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